@article{979b82441fd8409b97aeca6cbb68266b,
title = "A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum",
abstract = "Ureaplasma species, including Ureaplasma parvum and Ureaplasma urealyticum, are challenging to culture and maintain. Here, we describe a novel bioreactor for growing high-titer liquid Ureaplasma cultures in a stable manner.",
keywords = "Bioreactor, Culture, Growth, Ureaplasma, Ureaplasma parvum",
author = "Derek Fleming and Melissa Karau and Robin Patel",
note = "Funding Information: Dr. Patel reports grants from Merck, ContraFect, TenNor Therapeutics Limited and Shionogi. Dr. Patel is a consultant to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, and Qvella; monies are paid to Mayo Clinic. Dr. Patel is also a consultant to Netflix. In addition, Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. Dr. Patel receives an editor's stipend from IDSA, and honoraria from the NBME, Up-to-Date and the Infectious Diseases Board Review Course. Funding Information: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R21AI150649 . Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",
year = "2021",
month = feb,
doi = "10.1016/j.mimet.2020.106131",
language = "English (US)",
volume = "181",
journal = "Journal of Microbiological Methods",
issn = "0167-7012",
publisher = "Elsevier",
}